Project Details

Description

Randomized trial of the drug Remdisivir in Danish Corona patients
StatusActive
Effective start/end date27/03/2020 → …

Keywords

  • Corona
  • Corona virus
  • COVID-19
  • Remdisivir

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
  • Remdesivir for the Treatment of Covid-19 - Final Report

    Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., Lopez de Castilla, D., Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W. R., Touloumi, G. & 22 others, Lye, D. C., Ohmagari, N., Oh, M-D., Ruiz-Palacios, G. M., Benfield, T., Fätkenheuer, G., Kortepeter, M. G., Atmar, R. L., Creech, C. B., Lundgren, J., Babiker, A. G., Pett, S., Neaton, J. D., Burgess, T. H., Bonnett, T., Green, M., Makowski, M., Osinusi, A., Nayak, S., Lane, H. C., ACTT-1 Study Group Members & Nielsen, H., 5 Nov 2020, In: The New England Journal of Medicine. 383, 19, p. 1813-1826 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

    Open Access
    1799 Citations (Scopus)